Seminar on the occasion of the transit of the European Medicines Agency to Amsterdam (EMA), 27th & 29th of May
The seminar brings you a view from regulators, academia and industry on the necessity of maintaining the balance between regulation and innovation and will give you an update on the latest information on the transit of the EMA from the UK to The Netherlands. In addition you will be provided an overview of the excellent infrastructure for research and innovation in The Netherlands, and how the stakeholders are collaborating in the fields of regulations and innovation, with the goal of bringing new medicines and treatments to patients in Europe.
Speakers from the Netherlands include a chairman of the Dutch Clinical Trials Authority, a chairman of the Medicines Evaluation Board and a member of the Regulatory Affairs Working Group of the Dutch Pharmaceutical Medicine Association. Furthermore there will be two Chinese speakers from the regulatory science community and from the industry.
Location:
- Monday 27th of May, Embassy of The Netherlands in Beijing
- Wednesday 29th of May, Consulate of The Netherlands in Shanghai
There is a limited number of seats available and pre-registration is required.
Pre-registration can be done by sending an e-mail to this address:
Please indicate company name, your name and title, number of attendees, and preferred location (Beijing or Shanghai)
Seminar organized by the Embassy and Consulate of The Netherlands in China, The Netherlands Foreign Investment Agency and 3EACON Inc.